A carregar...
Response to pembrolizumab in a heavily treated patient with metastatic ovarian carcinosarcoma
BACKGROUND: Ovarian carcinosarcoma is a rare malignancy associated with a high rate of cancer-related mortality even at early stages. Guidelines for systemic treatment have been difficult to establish because the disease is commonly excluded from prospective clinical trials. Ovarian carcinosarcoma i...
Na minha lista:
| Publicado no: | Gynecol Oncol Res Pract |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6098839/ https://ncbi.nlm.nih.gov/pubmed/30147940 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40661-018-0063-3 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|